Tuberkulózis: ki dolgozik rajta

Intézményenként egy kártya. Szűrhetsz célpontra, országra, vagy csak az EU-13 (Horizon Europe felzárkózó) országok intézményeire.

• Minden célpont
• TNF 0
• IL-1 0
• IL-6 0
• IL-17 0
• STING 0
• NLRP3 0
• STAT3 0
• HMGB1 0
• JAK 0
• PD-1 0
• PI3K 0
• TLR4 0
• TP53 0
• TYK2 0
• AKT 0
• CTLA-4 0
• IL-23 0
• mTOR 0
• NRF2 0
• PPAR 0
• SIRT1 0
• CCR5 0
• CD40 0
• EGFR 0
• MAPK 0
• PD-L1 0
• ABL1 0
• AMPK 0
• CD20 0
• COX-2 0
• GPX4 0
• JNK 0
• TFEB 0
• TREM2 0
• VEGF 0
• YAP 0
• ALK 0
• ATM 0
• AXL 0
• BCL-2 0
• BRAF 0
• CD38 0
• FTO 0
• HDAC 0
• HIF-1 0
• HSP90 0
• IL-15 0
• IL-4 0
• MMP-9 0
• NOTCH3 0
• NTRK 0
• PDE4 0
• PKM2 0
• PRMT5 0
• PTEN 0
• STK11 0

Az EU-13 szűrő, nem rangsor: csak szűkíti a listát.

200+ intézményből 24, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Felfüggesztve

  Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

  NCT06192160· National Institute of Allergy and Infectious Diseases (NIAID)· Frissítve: 2026. nov. 2.

  “Temporarily Closed (Paused) to Accrual.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

  NCT02354014· Janssen Research & Development, LLC· Frissítve: 2026. szept. 17.

  “As part of the protocol-specified interim pharmacokinetic (PK) evaluation in Study TMC207-C211, PK data demonstrated lower-than-anticipated bedaquiline exposure”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam

  NCT06191692· Freundeskreis Für Internationale Tuberkulosehilfe e.V· Frissítve: 2026. szept. 9.

  “Lack of Rifapentine”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

  NCT04518228· National Institute of Allergy and Infectious Diseases (NIAID)· Frissítve: 2026. aug. 26.

  “The study was closed to accrual early based on Study Monitoring Committee review indicating that the study objectives had either been achieved or could not be met within a reasonable timeframe for the then-open arms.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  Effectiveness and Cost-Effectiveness of Depression Treatment for Individuals With TB in South Africa

  NCT05091580· New York State Psychiatric Institute· Frissítve: 2026. aug. 26.

  “Interruption in funding; Planned restart: October 2026”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

  NCT04694586· University Hospital, Linkoeping· Frissítve: 2026. aug. 17.

  “Suspended 15th of Nov 2023 due to conditions affecting recruitment process.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa

  NCT05539989· International Maternal Pediatric Adolescent AIDS Clinical Trials Group· Frissítve: 2026. aug. 17.

  “The study is no longer moving forward due to the changing TB vaccine landscape.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis

  NCT07517445· Gates Medical Research Institute· Frissítve: 2026. aug. 10.

  “A temporary precautionary pause in enrolment into all arms of the trial was implemented on 21 July 2026, due to emerging hepatic safety signal. A protocol amendment is currently underway.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study

  NCT04311502· National Institute of Allergy and Infectious Diseases (NIAID)· Frissítve: 2026. júl. 8.

  “Accrual was permanently closed due to futility in the experimental arm on June 22, 2023. Follow-up in the experimental arm was extended to 117 weeks.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis

  NCT04575519· Fundació Institut Germans Trias i Pujol· Frissítve: 2026. jún. 1.

  “The impact of the COVID-19 pandemic on TB diagnosis affected greatly the recruitment rate and posed challenges to the trial's timeline, consuming the funding needed to continue the enrolment.”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia

  NCT04926922· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

  NCT06192160· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients

  NCT03568383· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV

  NCT07124559· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women

  NCT07069582· McGill University Health Centre/Research Institute of the McGill University Health Centre· Forrás

• Re-evaluating the Duration in Children of TB Treatment

  NCT07656012· University of Wisconsin, Madison· Forrás

• Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma

  NCT00814827· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

  NCT07209761· Otsuka Pharmaceutical Development & Commercialization, Inc.· Forrás

• Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

  NCT07163143· University College, London· Forrás

• Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB

  NCT06568484· Johns Hopkins University· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 33
• Organoids 5
• Mendelian Randomization Analysis 7
• CRISPR-Cas Systems 25
• Gene Expression Profiling 103
• Sequence Analysis, RNA 11
• Whole Genome Sequencing 133
• Exome Sequencing 5
• Proteomics 47
• Metabolomics 39
• Mass Spectrometry 16
• Flow Cytometry 16
• Immunohistochemistry 9
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 84
• Machine Learning 102
• Deep Learning 41
• Cohort Studies 101
• Genome-Wide Association Study 12

• Differential diagnosis of pulmonary Talaromyces marneffei infection and pulmonary tuberculosis in HIV/AIDS patients using a CT-based multimodal 2.5D deep learning approach.

  Front Cell Infect Microbiol, 2026. okt.

• Diagnostic accuracy of a DenseNet-121 deep learning algorithm for chest radiograph triage in health assessment applicants: a prospective shadow-mode validation study in Nepal.

  BMJ Open, 2026. okt.

• Deep learning-based spatial immunoprofiling of multiplex immunofluorescence images distinguishes tuberculosis disease states in diversity outbred mice.

  PLoS One, 2026. szept.

• Deep learning extracts MoA-specific signatures from high-throughput images of chemically and genetically perturbed Corynebacteria.

  Sci Adv, 2026. szept.

• Efficient and accurate tuberculosis diagnosis: Attention Residual U-Net and vision transformer based detection framework.

  J Microbiol Methods, 2026. szept.

• A novel Ziehl-Neelsen sputum smear image database and deep learning strategy for automated detection of tuberculosis bacilli.

  Comput Biol Med, 2026. szept.

• DETECTX: a novel deep learning approach for detecting pneumonia, tuberculosis, and aspergillosis from chest X-rays.

  Front Cell Infect Microbiol, 2026. szept.

• A radiology-aware fuzzy deep learning framework with entropy-guided feature selection for robust multi-disease chest X-ray classification across multiple magnifications.

  Radiol Phys Technol, 2026. júl.

• A survey of explainable AI applications in infectious disease diagnosis.

  BMC Infect Dis, 2026. júl.

• Deep learning-based detection of acid-fast bacilli in microscopy images: a systematic review.

  Am J Clin Pathol, 2026. júl.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.